We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+7.44%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$25.3B
AUM Growth
+$2.28B
(+9.9%)
Cap. Flow
+$944M
Cap. Flow
% of AUM
3.73%
Top 10 Holdings %
Top 10 Hldgs %
31.14%
Holding
1,538
New
18
Increased
913
Reduced
179
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$115M |
| 2 |
Boston Scientific
BSX
|
+$76.1M |
| 3 |
AptarGroup
ATR
|
+$51.5M |
| 4 |
Halozyme
HALO
|
+$49.1M |
| 5 |
Fluence Energy
FLNC
|
+$37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$53.5M |
| 2 |
Broadcom
AVGO
|
+$37.8M |
| 3 |
WillScot Mobile Mini Holdings
WSC
|
+$37.5M |
| 4 |
TE Connectivity
TEL
|
+$26.7M |
| 5 |
NVIDIA
NVDA
|
+$23.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.77% |
| 2 | Healthcare | 19.94% |
| 3 | Financials | 10.69% |
| 4 | Industrials | 8.65% |
| 5 | Communication Services | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GTM
1201
ZoomInfo Technologies
GTM
$1.15B
| $562K | ﹤0.01% |
54,500
| – | – |
|
1202
ADT
ADT
$5.42B
| $556K | ﹤0.01% |
76,900
| – | – |
|
1203
ePlus
PLUS
$2.29B
| $555K | ﹤0.01% |
5,644
| – | – |
|
1204
Fox Factory Holding Corp
FOXF
$891M
| $553K | ﹤0.01% |
13,330
| – | – |
|
|
ENV
1205
DELISTED
ENVESTNET, INC.
ENV
| $552K | ﹤0.01% |
8,823
| – | – |
|
1206
Payoneer
PAYO
$2.42B
| $549K | ﹤0.01% |
72,900
+28,100
| +63% | +$182K |
|
|
PWSC
1207
DELISTED
PowerSchool Holdings, Inc.
PWSC
| $541K | ﹤0.01% |
23,700
+6,000
| +34% | +$136K |
|
1208
WaFd
WAFD
$2.8B
| $539K | ﹤0.01% |
15,474
| – | – |
|
1209
Sonos
SONO
$1.88B
| $537K | ﹤0.01% |
43,700
+14,700
| +51% | +$187K |
|
1210
Supernus Pharmaceuticals
SUPN
$2.74B
| $537K | ﹤0.01% |
17,216
| – | – |
|
1211
Ligand Pharmaceuticals
LGND
$5.73B
| $536K | ﹤0.01% |
5,358
+500
| +10% | +$50.3K |
|
1212
Franklin Resources
BEN
$17.2B
| $535K | ﹤0.01% |
26,558
| – | – |
|
1213
Criteo S.A. Ordinary Shares
CRTO
$898M
| $535K | ﹤0.01% |
13,300
+2,000
| +18% | +$87.9K |
|
1214
NovoCure
NVCR
$2.05B
| $535K | ﹤0.01% |
34,223
+5,000
| +17% | +$90.7K |
|
1215
Telephone and Data Systems
TDS
$3.97B
| $535K | ﹤0.01% |
23,025
+4,800
| +26% | +$105K |
|
1216
Vishay Intertechnology
VSH
$5.2B
| $535K | ﹤0.01% |
28,297
| – | – |
|
1217
John Wiley & Sons Class A
WLY
$2.6B
| $533K | ﹤0.01% |
11,037
+1,600
| +17% | +$73.5K |
|
1218
Viavi Solutions
VIAV
$10.6B
| $531K | ﹤0.01% |
58,910
+7,300
| +14% | +$57.9K |
|
1219
Enova International
ENVA
$6.57B
| $528K | ﹤0.01% |
6,300
| – | – |
|
1220
Brighthouse Financial
BHF
$3.42B
| $527K | ﹤0.01% |
11,700
| – | – |
|
1221
Marriott Vacations Worldwide
VAC
$4.14B
| $527K | ﹤0.01% |
7,177
| – | – |
|
1222
HNI Corp
HNI
$3.58B
| $524K | ﹤0.01% |
9,726
| – | – |
|
1223
CleanSpark
CLSK
$2.96B
| $523K | ﹤0.01% |
56,000
+13,700
| +32% | +$174K |
|
1224
Brady Corp
BRC
$4.44B
| $522K | ﹤0.01% |
6,809
| – | – |
|
1225
Independent Bank
INDB
$4.04B
| $522K | ﹤0.01% |
8,829
| – | – |
|
Similar funds
VIA
GAM
Handelsbanken Fonder's Q3 2024 Portfolio in Review
As of Q3 2024, Handelsbanken Fonder held 1,538 positions worth $25.3B, up 9.9% from $23B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Handelsbanken Fonder deployed $944M of net new capital in Q3 2024, opening 18 new positions and adding to 913 existing holdings. Its largest new stake was Edison International: 24,542 shares worth $2.14M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Edwards Lifesciences, an estimated $53.5M trimmed.
- Handelsbanken Fonder's largest Q3 2024 buy was Edison International: 24,542 shares worth $2.14M.
- Handelsbanken Fonder added most to Merck in Q3 2024, an estimated $115M increase.
- Handelsbanken Fonder's biggest Q3 2024 reduction was Edwards Lifesciences, cutting an estimated $53.5M.
- Handelsbanken Fonder fully exited TE Connectivity in Q3 2024, selling an estimated $26.7M.
- Handelsbanken Fonder's ten largest holdings make up 31% of its $25.3B portfolio in Q3 2024.
- Handelsbanken Fonder opened 18 new positions and closed 16 in Q3 2024.
- Handelsbanken Fonder's portfolio value rose 9.9% quarter-over-quarter to $25.3B.
Based on Handelsbanken Fonder's 13F filing for Q3 2024, filed 4 Oct 2024.